Literature DB >> 16979312

Nitric oxide inhibitory substances from the rhizomes of Dioscorea membranacea.

Supinya Tewtrakul1, Arunporn Itharat.   

Abstract

Thai medicinal plants locally known as Hua-Khao-Yen were examined for their inhibitory activities against lipopolysaccharide (LPS) induced nitric oxide (NO) production in RAW 264.7 cell lines. Among the plant species studied, an ethanolic extract of Dioscorea membranacea exhibited the most potent inhibitory activity, with an IC(50) value of 23.6 microg/ml. From this extract, eight compounds [two naphthofuranoxepins (1, 2), one phenanthraquinone (3), three steroids (4-6) and two steroidal saponins (7, 8)] were isolated and further investigated for their inhibitory properties of NO production. It was found that diosgenin-3-O-alpha-L-rhamnosyl (1-->2)-beta-D-glucopyranoside (7) possessed the highest activity (IC(50)=3.5 microM), followed by dioscoreanone (3, IC(50)=9.8 microM) and dioscorealide B (2, IC(50)=24.9 microM). Regarding structural requirements of diosgenin derivatives for NO production inhibitory activity, compound 7 which has a rhamnoglucosyl moiety at C-3 exhibited much higher activity than compounds that have either a diglucosyl substitution (8) or its aglycone (9); whereas, hydroxyl substitution at position 8 of naphthofuranoxepin derivatives conferred higher activity than the methoxyl group. It is concluded that diosgenin-3-O-alpha-L-rhamnosyl (1-->2)-beta-D-glucopyranoside (7), dioscoreanone (3) and dioscorealide B (2) are active principles for NO inhibitory activity of Dioscorea membranacea. Compounds 1-3 were also tested for the inhibitory effect on LPS-induced TNF-alpha release in RAW 264.7 cells. The result revealed that 3 possessed potent activity against TNF-alpha release with an IC(50) value of 17.6 microM, whereas, 1 and 2 exhibited mild activity. The present study may support the use of Dioscorea membranacea by Thai traditional doctors for treatment of the inflammatory diseases.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16979312     DOI: 10.1016/j.jep.2006.08.009

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  4 in total

1.  Effects of Dioscoreae Rhizoma (SanYak) on Peripheral Neuropathy and its Safety.

Authors:  Min-Jung Kim; Hyunkyung Sung; Kwon-Eui Hong
Journal:  J Pharmacopuncture       Date:  2013-09

2.  Growth arrest and apoptosis via caspase activation of dioscoreanone in human non-small-cell lung cancer A549 cells.

Authors:  Pintusorn Hansakul; Kalaya Aree; Sermkiat Tanuchit; Arunporn Itharat
Journal:  BMC Complement Altern Med       Date:  2014-10-24       Impact factor: 3.659

3.  Immunomodulatory Effects of Dioscoreae Rhizome Against Inflammation through Suppressed Production of Cytokines Via Inhibition of the NF-κB Pathway.

Authors:  Seulah Kim; Seulmee Shin; Bobae Hyun; Hyunseok Kong; Shinha Han; Aeri Lee; Seungjeong Lee; Kyungjae Kim
Journal:  Immune Netw       Date:  2012-10-31       Impact factor: 6.303

4.  Solvent Extraction and Identification of Active Anticariogenic Metabolites in Piper cubeba L. through ¹H-NMR-Based Metabolomics Approach.

Authors:  Raja Nur Asila Raja Mazlan; Yaya Rukayadi; M Maulidiani; Intan Safinar Ismail
Journal:  Molecules       Date:  2018-07-16       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.